BridgeMD
Tests treatment safety and results for Small Intestine Bacterial Overgrowth
Official title Comparative Efficacy of Antibiotics for Small Intestine Bacterial Overgrowth in Bangladeshi Children
ClinicalTrials.gov ID: NCT07451171
What this study is testing
What is Trimethoprim-sulfamethoxazole (TMP/SMX)?
Trimethoprim-sulfamethoxazole (TMP/SMX) is an investigational medicine, being studied as a potential treatment for small intestine bacterial overgrowth.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this Phase IIa study is to identify the most effective antibiotic regimen to treat small intestine bacterial overgrowth (SIBO) in impoverished Bangladeshi children.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 2
You may be able to join if
- Positive glucose hydrogen breath test (GHBT)
- Weight-for-age Z score \> -1
- Length-for-age Z score \> -1
You likely can't join if
- Presence of known chronic or congenital illness, including developmental delay
- Presence of acute gastrointestinal illness in the preceding 14 days
- Antibiotic use in the preceding 14 days
- Previous adverse reaction to any of the three study medications or other drugs in the same antibiotic classes
- Sibling previously enrolled in this study
The study team makes the final eligibility decision.
Where it's taking place
- Dhaka, Bangladesh
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 year to 2 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dhaka, Bangladesh. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.